The groundbreaking immunology research behind two Nobel Prizes awarded this week traces back to a largely forgotten biotech startup backed by Bill Gates and Paul Allen. Read More
Mary Brunkow of the Seattle-based Institute for Systems Biology, Fred Ramsdell of Sonoma Biotherapeutics, and David Baker of the UW’s Institute for Protein Design were honored for their research. Read More
Seattle scientist Mary Brunkow of the Institute for Systems Biology (ISB) won a Nobel Prize for research on the immune cells that prevent our body from attacking itself. Read More
Alpyne Labs created its AI-powered tool to take care of benefits checks, billing, scheduling, notes organization and more to free up therapists to concentrate on patient care. Read More
A consortium of top U.S. cancer centers has developed an AI platform that trains models on clinical data from multiple institutions while protecting patient privacy, with the goal of cutting the timeline for new discoveries in cancer research from years to months. Read More
As new startups and initiatives continue to bolster its standing, Seattle is being called “the best place in the world to build an AI life sciences company.” Read More
The Seattle-based biotech company aims to make new drug discovery faster and cheaper by using AI to simulate the results from hypothetical lab tests. Read More
LumiThera’s key innovation is a device for use by ophthalmologists that improves vision and slows its loss, with a focus on patients with dry age-related macular degeneration. Read More
Once a scrappy startup lab, Fred Hutchinson Cancer Center is now a global leader in cancer research. As it turns 50, the Seattle institution faces federal funding cuts that could slow progress. Read More
AI will transform healthcare in the next 1-2 years by connecting directly to personal medical records to give patients new levels of health insights, current and former Microsoft execs predicted Tuesday. Read More
Lila Biologics hopes to hand off a candidate protein within three to six months so the pharmaceutical giant can take the drug through clinical trials. Read More
The wiggly targets known to scientists as “intrinsically disordered proteins” have for decades eluded capture by custom-made drugs and antibodies.… Read More
PATH’s ribbon-cutting ceremony this week should have been purely celebratory. Instead, the global health nonprofit’s move to airy new Seattle… Read More
Circulate Health, a Seattle healthy longevity startup, today announced $12 million in seed funding. The company is partnering with two-dozen… Read More
Microsoft today announced an artificial intelligence tool that outperformed a panel of medical doctors in diagnosing complicated cases. The Microsoft… Read More
Reperio Health, a Portland, Ore.-based startup providing in-home health screenings, raised $14 million in funding, Endpoints News reports. The new… Read More
